论文部分内容阅读
Objectives Current evidence regarding the successof drug-eluting balloons (DEBs) for de novo coronary artery disease is insufficient for formulating formal recommendations.This study aimed to evaluate the effectiveness of DEBs by performing a meta-analysis of randomised controlled trials (RCTs).